Market Timing with TurnerTrends Provides Great Stock Picks for the Sophisticated Investor   Timing the Market well requires Stock Picks that work
Home Subscribe! Master Portfolios StockMasterPro ETFMasterPro Partners Members
Top 100 Stocks | Search Stocks | Sector Analyzer | Industry Analyzer
New Hot Stock Picks | How we Rate Stocks | Tutorial
My Stock Watch Lists: Add+
Ticker: 

TurnerTrends Stock Rating Report for ANX

Data valid for week beginning October 06, 2008

Ticker Company Name
ANX   [News] Adventrx Pharmaceuticals Inc
Company Profile
"ADVENTRX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates primarily for the treatment of cancer and infectious disease in the United States. Its products include ANX-530, a novel emulsion formulations of chemotherapy drugs to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin- and ANX-514, a novel emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. The company also involves in developing ANX-510, or CoFactor, a folate-based biomodulator designed to replace leucovorin as the preferred method to enhance the activity and reduce the associated toxicity of cancer chemotherapeutic agent 5-fluorouracil. In addition, ADVENTRX hold rights of other compounds that the company is evaluating for future preclinical and clinical development, including ANX-015, a novel formulation of clarithromycin for the treatment of mild to moderate bacterial infections, such as community-acquired pneumonia- ANX-016, an intravenous formulation of vancomycin for the treatment of gram-positive bacterial infections- and ANX-201, a member of a new class of reverse transcriptase inhibitor for a spectrum of antiviral activity against human immunodeficiency virus, human and avian influenza viruses, and herpes simplex viruses. Further, its developing components comprise ANX-513, a novel formulation of paclitaxel for the treatment of breast, ovarian, Kaposi’s sarcoma, and non-small cell lung cancers- and ANX-575, a novel formulation of alpha-tocopheryl succinate used to facilitate cell death in cancer cells. The company was founded in 1995 is headquartered in San Diego, California."

Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
Technical Chart (3 year) Sector Chart Industry Chart

ANX Technical Chart

We use technical analysis and fundamental analysis to recommend ratings for thousands of stocks. If you had a subscription, this space would show our 3 year history of trades for ANX. However, we only show it to our subscribers.

We update our ratings and stop losses EVERY WEEK.

Don't miss out on what we recommend for Adventrx Pharmaceuticals Inc next week. Sign up today and start making money!

FREE TRIAL!!


Stock Information
Friday's Close $0.21
Volume Avg. 611392 shares
Industry Biotechnology
Sector Healthcare
Our Stop Loss Members Only
Expected Move Members Only
Optionable? Yes

Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
Stock Financials
Profit Margin .00%
Operating Margin -4997.90%
Debt-to-Equity .00%
P/E ttm 0.00
EPS ttm $-0.262
EBITDA $-24,810,000
Total Revenue $Unknown
Market Cap $23,460
Annual Dividend $.00
Yield .000%
ROE -78.30%
Revenue Growth Rate Quarterly 0.00%
Earnings Growth Rate Quarterly -12.30%
Earnings Growth Rate Yearly 0.00%
Revenue Growth Rate Average 61.15%
Earnings Growth Rate Average 0.00%
Institutional Ownership Members Only
Value Rating Members Only
TurnerTrends Score Members Only


Latest News

Fri, 29 Aug 2008 13:04:22 Etc/GMTADVENTRX PHARMACEUTICALS INC Financials (EDGAR Online Financials)
Tue, 12 Aug 2008 13:23:12 Etc/GMTNew Star Analyst Rankings for ADVENTRX PHARMACTL (StarMine)
Tue, 12 Aug 2008 11:07:08 Etc/GMTQ2 2008 ADVENTRX PHARMACEUTICALS INC Earnings Release - Time Not Supplied (CCBN)
Mon, 11 Aug 2008 20:05:13 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online)
Mon, 11 Aug 2008 20:01:00 Etc/GMTADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update (PR Newswire)
Mon, 11 Aug 2008 18:58:46 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (EDGAR Online)
Fri, 8 Aug 2008 10:00:00 Etc/GMTADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results (PR Newswire)
Tue, 1 Jul 2008 10:10:33 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Tue, 3 Jun 2008 10:03:12 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online)
Mon, 2 Jun 2008 21:06:40 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (EDGAR Online)
Wed, 28 May 2008 16:00:00 Etc/GMTToday's 5-Star Movers (at Motley Fool)
Tue, 20 May 2008 12:01:52 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
Mon, 12 May 2008 10:07:45 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online)
Tue, 29 Apr 2008 14:02:26 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (EDGAR Online)
Mon, 7 Apr 2008 20:10:35 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and (EDGAR Online)
Fri, 4 Apr 2008 19:03:26 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Tue, 25 Mar 2008 20:08:08 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
Mon, 17 Mar 2008 10:00:59 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 10-K, Annual Report (EDGAR Online)
Thu, 13 Mar 2008 20:10:01 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (EDGAR Online)
Thu, 6 Mar 2008 17:26:32 Etc/GMTADVENTRX PHARMACEUTICALS INC Files SEC form 8-K/A, Change in Directors or Principal Officers (EDGAR Online)
News provided by Yahoo! Finance
Home | Stock Portfolios | Stock Ratings | Top 100 Stocks | New Hot Stock Picks | Sector Analyzer | Industry Analyzer | Member's Area | Articles | FAQ | Contact Us | Terms of Use | Advertise
(C) Copyright TurnerTrends, Inc.  All Rights Reserved.

*Past performance does not guarantee future results. TurnerTrends makes no representations or warrants that just because a stock would have made a profit in the past, using TurnerTrends buy recommendations or sell recommendations, it will make any profits in the future. It is possible that these same stocks will lose money in the future using the TurnerTrends stock recommendations.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither TurnerTrends nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the TurnerTrends site, a user agrees not to redistribute the information found therein.